Jennifer M. Yeh, PhD; Anju Nohria, MD; Lisa Diller, MD
Cardiac assessment every 1 to 5 years for childhood cancer survivors is recommended to detect asymptomatic left ventricular dysfunction. The authors estimated the clinical benefits and cost-effectiveness of these assessments with subsequent treatment with angiotensin-converting inhibitors and β-blockers for patients with positive test results to reduce the incidence of symptomatic congestive heart failure. They concluded that less frequent assessment than currently recommended may be more cost-effective.
Ann Intern Med. 2014;160(10):661-671. doi:10.7326/M13-2266
F. Lennie Wong, PhD; Smita Bhatia, MD, MPH; Wendy Landier, PhD, RN; Liton Francisco, BS; Wendy Leisenring, ScD; Melissa M. Hudson, MD; Gregory T. Armstrong, MD; Ann Mertens, PhD; Marilyn Stovall, PhD; Leslie L. Robison, PhD; Gary H. Lyman, MD, MPH; Steven E. Lipshultz, MD; Saro H. Armenian, DO, MPH
Childhood cancer survivors treated with anthracyclines are at high risk for asymptomatic left ventricular dysfunction, subsequent symptomatic heart failure, and death. The authors developed a cost-effectiveness model to evaluate the cost-effectiveness of the Children's Oncology Group Long-Term Follow-up Guidelines, which recommend lifetime echocardiographic screening every 1 to 5 years in this population. They conclude that less-frequent screening is more cost-effective than current guidelines and maintains 80% of the health benefits.
Ann Intern Med. 2014;160(10):672-683. doi:10.7326/M13-2498
Nayer Khazeni, MD, MS; David W. Hutton, MS, PhD; Cassandra I.F. Collins, MPH; Alan M. Garber, MD, PhD; Douglas K. Owens, MD, MS
Large-scale vaccination did not occur until 9 months into the 2009 influenza A (H1N1) pandemic. Researchers developed a model to estimate the reduction in morbidity, mortality, and health care costs that could be achieved during a pandemic by more rapid vaccination and more aggressive nonpharmaceutical strategies, such as school closings and hand washing, to mitigate infection. The results suggest that more rapid vaccination (by 4 to 6 months) would yield substantial reductions in infections, deaths, and health care costs. Nonpharmaceutical strategies that reduced contacts by 8% yielded similar results to delivering vaccine by 4 months.
Ann Intern Med. 2014;160(10):684-694. doi:10.7326/M13-2071
Jillian T. Henderson, PhD, MPH; Evelyn P. Whitlock, MD, MPH; Elizabeth O’Connor, PhD; Caitlyn A. Senger, MPH; Jamie H. Thompson, MPH; Maya G. Rowland, MPH
Preeclampsia is a leading cause of maternal and perinatal death. This systematic review, conducted to support the U.S. Preventive Services Task Force, assessed the benefits and harms of low-dose aspirin for preventing morbidity and mortality from preeclampsia. Its findings suggest that daily low-dose aspirin can prevent clinically important health outcomes, although potential rare or long-term harms could not be ruled out.
Ann Intern Med. 2014;160(10):695-703. doi:10.7326/M13-2844
Silvio Danese, MD, PhD; Gionata Fiorino, MD, PhD; Laurent Peyrin-Biroulet, MD, PhD; Ersilia Lucenteforte, ScD, PhD; Gianni Virgili, MD; Lorenzo Moja, MD, MSc, DrPH; Stefanos Bonovas, MD, MSc, PhD
Biological agents, including adalimumab, golimumab, infliximab, and vedolizumab, are emerging treatment options for ulcerative colitis. This systematic review found that all biological agents were superior to placebo for induction therapy and had greater efficacy than placebo for maintenance therapy for moderately to severely active ulcerative colitis. Indirect comparisons suggested that infliximab is more likely to induce a favorable clinical outcome than adalimumab. Biological agents are more effective than placebo, but head-to-head trials are needed to determine the best treatment option.
Ann Intern Med. 2014;160(10):704-711. doi:10.7326/M13-2403
Peter W. Marks, MD, PhD
This Update summarizes studies published in 2013 that the authors consider highly relevant to the practice of hematology and oncology.
Ann Intern Med. 2014;160(10):712-718. doi:10.7326/M14-0092
Michael L. LeFevre, MD, MSPH; on behalf of the U.S. Preventive Services Task Force
This recommendation from the U.S. Preventive Services Task Force found insufficient evidence to assess the balance of benefits and harms of screening for suicide risk in adolescents, adults, and older adults in a primary care setting.
Ann Intern Med. 2014;160(10):719-726. doi:10.7326/M14-0589
Christine A. Sinsky, MD; John W. Beasley, MD; Greg E. Simmons, MA; Richard J. Baron, MD
Use of electronic health records (EHRs) has grown over the past decade. The authors of this commentary believe that EHRs are inconsistently aligned with the needs of primary care patients and physicians. They propose a set of design, implementation, and policy principles for EHRs that support higher-value primary care.
Ann Intern Med. 2014;160(10):727-728. doi:10.7326/M13-2589
Andrew M. Ryan, PhD; Alvin I. Mushlin, MD, ScM
Hospitals have remained consistent in their share of health care expenditures despite dramatic changes in the payment and financing of care, including the passage of the Patient Protection and Affordable Care Act. This commentary discusses how they have done this and what it portends for health care reform.
Ann Intern Med. 2014;160(10):729-730. doi:10.7326/M13-2033
Richard M. Steingart, MD; Jennifer E. Liu, MD; Kevin C. Oeffinger, MD
In this issue, 2 articles examine the cost-effectiveness of routine screening to detect asymptomatic left ventricular dysfunction and reduce risks for congestive heart failure in childhood cancer survivors. The editorialists discuss the findings and stress that clinicians and patients should weigh the benefits and risks when determining the screening method and frequency.
Ann Intern Med. 2014;160(10):731-732. doi:10.7326/M14-0823
Ole Haagen Nielsen, MD, DMSc; Mark Andrew Ainsworth, MD, PhD, DMSc
In this issue, Danese and colleagues review the efficacy and safety of biological treatment options for ulcerative colitis. The editorialists discuss the review's findings and believe that, although the data are helpful in making clinical decisions, biological agents need to be compared directly.
Ann Intern Med. 2014;160(10):733-734. doi:10.7326/M14-0605
Janani Rangaswami, MD
I walked into the hospital on Monday morning not knowing what to expect in the aftermath of a long weekend. Among those admitted for asthma, stroke, and pneumonia, one patient's description caught my eye.
Ann Intern Med. 2014;160(10):735-736. doi:10.7326/M13-2834
Ann Intern Med. 2014;160(10):737. doi:10.7326/L14-5010
Ann Intern Med. 2014;160(10):737-738. doi:10.7326/L14-5010-2
Ann Intern Med. 2014;160(10):738. doi:10.7326/L14-5010-3
Ann Intern Med. 2014;160(10):738. doi:10.7326/L14-5010-4
Ann Intern Med. 2014;160(10):738-739. doi:10.7326/L14-5010-5
Ann Intern Med. 2014;160(10):739. doi:10.7326/L14-5010-6
Jo Persoon-Gundy, MD
Ann Intern Med. 2014;160(10):740. doi:10.7326/M13-2535
Brian H. Rowe, MD, MSc
Ann Intern Med. 2014;160(10):JC2. doi:10.7326/0003-4819-160-10-201405200-02002
Sameer S. Kadri, MD; Naomi P. O’Grady, MD
Ann Intern Med. 2014;160(10):JC3. doi:10.7326/0003-4819-160-10-201405200-02003
Hanna E. Bloomfield, MD, MPH
Ann Intern Med. 2014;160(10):JC4. doi:10.7326/0003-4819-160-10-201405200-02004
Yee C. Lau, MD; Gregory Y.H. Lip, MD
Ann Intern Med. 2014;160(10):JC5. doi:10.7326/0003-4819-160-10-201405200-02005
A.C. Felix Burden, MB, MD, FRCP
Ann Intern Med. 2014;160(10):JC6. doi:10.7326/0003-4819-160-10-201405200-02006
Suzanne W. Fletcher, MD
Ann Intern Med. 2014;160(10):JC7. doi:10.7326/0003-4819-160-10-201405200-02007
Saul Schaefer, MD
Ann Intern Med. 2014;160(10):JC8. doi:10.7326/0003-4819-160-10-201405200-02008
Amber O. Molnar, MD; Amit X. Garg, MD
Ann Intern Med. 2014;160(10):JC9. doi:10.7326/0003-4819-160-10-201405200-02009
Donald A. Smith, MD, MPH
Ann Intern Med. 2014;160(10):JC10. doi:10.7326/0003-4819-160-10-201405200-02010
Ann Intern Med. 2014;160(10):JC11. doi:10.7326/0003-4819-160-10-201405200-02011
Amit X. Garg, MD, PhD; Neil Boudville, MD
Ann Intern Med. 2014;160(10):JC12. doi:10.7326/0003-4819-160-10-201405200-02012
Maura Marcucci, MD
Ann Intern Med. 2014;160(10):JC13. doi:10.7326/0003-4819-160-10-201405200-02013
Geno J. Merli, MD; Howard H. Weitz, MD
The Consult Guys bring a new perspective to the art and science of medicine with lively discussion and analysis of real-world cases and situations.
Ann Intern Med. 2014;160(10):CG5. doi:10.7326/G14-3005
Ann Intern Med. 2014;160(10):I-22. doi:10.7326/P14-9016
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use